Skandinaviska Enskilda Banken (SEB)’s Takeda Pharmaceutical TAK Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,034	Closed	-$92K	–	1193
2020 Q4	$92K	Sell	5,034 -2,114	-30%	-$37.1K	﹤0.01%	1051
2020 Q3	$128K	Hold	7,148	–	–	﹤0.01%	928
2020 Q2	$128K	Hold	7,148	–	–	﹤0.01%	945
2020 Q1	$108K	Hold	7,148	–	–	﹤0.01%	860
2019 Q4	$141K	Sell	7,148 -1,510	-17%	-$28.9K	﹤0.01%	873
2019 Q3	$149K	Hold	8,658	–	–	﹤0.01%	849
2019 Q2	$153K	Buy	+8,658	New	+$158K	﹤0.01%	784

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s TAK Position: Q1 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Takeda Pharmaceutical (TAK) in Q1 2021, closing a stake of 5,034 shares — an estimated $92K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in TAK in Q2 2019 and held it in 7 quarters. The position peaked at $153K in Q2 2019. 317 funds tracked by Wall St. Rank hold TAK as of Q1 2021.

Skandinaviska Enskilda Banken (SEB) reported no remaining Takeda Pharmaceutical position as of Q1 2021 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 5,034 Takeda Pharmaceutical shares in Q1 2021, an estimated $92K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Takeda Pharmaceutical in Q2 2019 and held it in 7 quarters.
Skandinaviska Enskilda Banken (SEB)'s Takeda Pharmaceutical position peaked at $153K in Q2 2019.
317 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2021, filed 14 May 2021.